Unknown OBSERVATIONAL NCT04694391

Genomic Study of Relapse Esophageal Cancer After Radiotherapy

Sponsor: Fudan University

Conditions Esophageal Cancer Gene Mutation-Related Cancer Radiation Exposure

Updated 5 times since 2021 Last updated: Jan 24, 2021 Started: Sep 14, 2012 Primary completion: Dec 31, 2020 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Esophageal Cancer and Gene Mutation-Related Cancer and is currently ongoing. Fudan University leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Feb 2023 [monthly]

Recruiting
Feb 2021 — Dec 2021 [monthly]

Recruiting

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fudan University
Henan Cancer Hospital
Jiangsu Cancer Institute & Hospital
M.D. Anderson Cancer Center
Nantong University
Ningbo No.2 Hospital
Taian Cancer Hospital
Taihe Hospital

Data source: Fudan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China